Literature DB >> 17434501

Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.

Nancy E Reame1, Jane L Lukacs, Pamela Olton, Rudi Ansbacher, Vasantha Padmanabhan.   

Abstract

To assess the involvement of ovarian-derived regulatory proteins in FSH modulation, we compared FSH, inhibin A, inhibin B, activin A, and follistatin (FS) in 79 women from the following five groups: young cycling, older cycling, perimenopause (PERI), spontaneous menopause (PM), and surgical menopause receiving estrogen (OVX+ET). Although inhibin B varied as expected by ovarian function, no group differences were observed in activin A, barring a tendency for an increase in PERI, while FS 288 was lower in the PERI, PM, and OVX+ET groups and negatively correlated with advancing age.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17434501      PMCID： PMC2075352          DOI： 10.1016/j.fertnstert.2006.12.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  17 in total

1.  Actions of activins, inhibins and follistatins: implications in anterior pituitary function.

Authors:  L M Bilezikjian; A L Blount; A Z Corrigan; A Leal; Y Chen; W W Vale
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-03       Impact factor: 2.557

Review 2.  Neuroendocrine vs. paracrine control of follicle-stimulating hormone.

Authors:  V Padmanabhan; T P Sharma
Journal:  Arch Med Res       Date:  2001 Nov-Dec       Impact factor: 2.235

Review 3.  Paracrine regulation of reproductive function by inhibin and activin.

Authors:  J P Mather; T K Woodruff; L A Krummen
Journal:  Proc Soc Exp Biol Med       Date:  1992-10

4.  Measurement of dimeric inhibin B throughout the human menstrual cycle.

Authors:  N P Groome; P J Illingworth; M O'Brien; R Pai; F E Rodger; J P Mather; A S McNeilly
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

5.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.

Authors:  J J Lebrun; W W Vale
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.

Authors:  John F Randolph; MaryFran Sowers; Ellen B Gold; Beth A Mohr; Judith Luborsky; Nanette Santoro; Daniel S McConnell; Joel S Finkelstein; Stanley G Korenman; Karen A Matthews; Barbara Sternfeld; Bill L Lasley
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

7.  Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.

Authors:  S Muttukrishna; P A Fowler; L George; N P Groome; P G Knight
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

8.  Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.

Authors:  N P Groome; P J Illingworth; M O'Brien; I Cooke; T S Ganesan; D T Baird; A S McNeilly
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

9.  Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women.

Authors:  N Santoro; T Adel; J H Skurnick
Journal:  Fertil Steril       Date:  1999-04       Impact factor: 7.329

10.  Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.

Authors:  A L Schneyer; H A Hall; G Lambert-Messerlian; Q F Wang; P Sluss; W F Crowley
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736
View more
  10 in total

1.  Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging.

Authors:  Nancy E Reame; Jane L Lukacs; Vasantha Padmanabhan; Aimee D Eyvazzadeh; Yolanda R Smith; Jon-Kar Zubieta
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

2.  Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.

Authors:  A L Lukefahr; J B Frye; L E Wright; S L Marion; P B Hoyer; J L Funk
Journal:  Calcif Tissue Int       Date:  2012-01-17       Impact factor: 4.333

Review 3.  Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso
Journal:  Mol Cell Endocrinol       Date:  2019-11-02       Impact factor: 4.102

Review 4.  The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.

Authors:  Darcie D Seachrist; Ruth A Keri
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 5.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

6.  Follicle stimulating hormone and its rate of change in defining menopause transition stages.

Authors:  MaryFran R Sowers; Huiyong Zheng; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

Review 7.  Hormone Replacement Therapy: Would it be Possible to Replicate a Functional Ovary?

Authors:  Swati Agarwal; Faisal A Alzahrani; Asif Ahmed
Journal:  Int J Mol Sci       Date:  2018-10-14       Impact factor: 5.923

8.  Different anti-Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes.

Authors:  Rena Ishii; Naoyuki Tachibana; Riho Okawa; Megumi Enomoto; Mai Asami; Rena Toriumi; Michiko Hamada; Michiharu Horikawa; Yoko Akiba; Yuji Taketani
Journal:  Reprod Med Biol       Date:  2019-04-04

9.  The Ovarian Transcriptome of Reproductively Aged Multiparous Mice: Candidate Genes for Ovarian Cancer Protection.

Authors:  Ulises Urzúa; Carlos Chacón; Maximiliano Norambuena; Luis Lizama; Sebastián Sarmiento; Esther Asaki; John I Powell; Sandra Ampuero
Journal:  Biomolecules       Date:  2020-01-09

Review 10.  Ovarian Aging: Role of Pituitary-Ovarian Axis Hormones and ncRNAs in Regulating Ovarian Mitochondrial Activity.

Authors:  Marco Colella; Danila Cuomo; Teresa Peluso; Ilaria Falanga; Massimo Mallardo; Mario De Felice; Concetta Ambrosino
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-16       Impact factor: 5.555
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.